Tafenoquine Thorough QTc Study in Healthy Subjects

Summary

This will be a randomized, single-blind, placebo controlled, parallel group study. Approximately 260 subjects will be enrolled in five groups. This study is designed to compare the effects of tafenoquine, administered as single dose as well as administered over three consecutive days, on the changes in QT duration to those observed in subjects dosed with either moxifloxacin or placebo.

Timeline

Start

2011-07-26

Primary completion

2012-06-04

Completion

2012-06-04

Drugs

Indications